In this session we share with you the first results of the Rx-pilot from DICA, the PHARMO Institute and X-IS. During the Rx-pilot data from the Dutch Surgical Clinical Auditing (DSCA), hospital pharmacy and finance of one hospital were linked. This provides new insights into prescribed medication on a patient level, in what quantity, and the similarities and differences between patient groups (i.e. tumour location, ASA score, age).  This could improve the efficient use of expensive medicine in all Dutch hospitals. For more information click here.